Adrenomedullin in hypertension Richard D. TroughtonJohn G. LainchburyM. Gary Nicholls Invited Commentary Pages: 1 - 2
Xenobiotics, dietary interventions, and genetically mediated therapies Nicholas J. Schork Clinical Trials Review Pages: 11 - 12
Selecting the right drug for initial antihypertensive therapy Alan B. Weder Clinical Trials Review Pages: 13 - 15
Heredity and the autonomic nervous system in human hypertension Daniel T. O’ConnorPaul A. InselRobert J. Parmer OriginalPaper Pages: 16 - 22
Use of single nucleotide polymorphisms for gene discovery in hypertension Myriam FornagePeter A. Doris OriginalPaper Pages: 23 - 31
The role of β2-adrenergic receptor variation in human hypertension Molly S. BrayEric Boerwinkle OriginalPaper Pages: 39 - 43
Hypertension and single nucleotide polymorphisms Mark J. RiederDeborah A. Nickerson OriginalPaper Pages: 44 - 49
Antihypertensive drugs and reversing of endothelial dysfunction in hypertension Stefano TaddeiAgostino VirdisAntonio Salvetti OriginalPaper Pages: 64 - 70
Carotid intima-media thickness as a measure of vascular target organ damage G. B. John Mancini OriginalPaper Pages: 71 - 77
Role of adhesion molecules in vascular regulation and damage Anitaben TailorD. Neil Granger OriginalPaper Pages: 78 - 83
Endothelial dysfunction and atherosclerosis: Endothelin receptor antagonists as novel therapeutics Matthias Barton OriginalPaper Pages: 84 - 91
Gene therapy of hypertensive vascular injury Yi ChuFrank M. FaraciDonald D. Heistad OriginalPaper Pages: 92 - 97
Regulation of matrix proteins and impact on vascular structure José TuñónMarta Ruiz-OrtegaJesús Egido OriginalPaper Pages: 106 - 113
